Presentation AHA 2024 Efficacy and safety of EdoxabaN in anticoagulant therapy after surgical Bioprosthetic vALVe replacement Presenter: Chisato Izumi November 17, 2024
News Conference News AHA 2024 ENBALV: Edoxaban Matches Warfarin After Bioprosthetic Valve Surgery Yael L. Maxwell November 17, 2024
News Conference News AHA 2021 PALACS: Posterior Left Pericardiotomy Cuts Postop AF After Cardiac Surgery Todd Neale November 14, 2021
News Conference News AHA 2021 Tricuspid Repair During Mitral Surgery Slows Disease Progression at 2 Years Caitlin E. Cox November 13, 2021
News Opinion Editor's Corner AHA 2021 AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More Shelley Wood November 08, 2021
News Conference News AHA 2015 At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation L.A. McKeown November 08, 2015
News Conference News AHA 2014 Mitral Repair at the Time of CABG Provides No Mortality, QoL Benefit at 1 Year Yael L. Maxwell November 17, 2014
News Conference News AHA 2012 RIME: Mitral Annuloplasty Plus CABG Improves Functional Capacity, Regurgitation Jason Kahn November 06, 2012